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http://www.biomedcentral.com/1471-2393/14/241RESEARCH ARTICLE Open AccessProstaglandin pathway gene expression in human
placenta, amnion and choriodecidua is differentially
affected by preterm and term labour and by
uterine inflammation
Robert J Phillips1, Michel A Fortier2 and Andrés López Bernal1,3*Abstract
Background: Elucidation of the biochemical pathways involved in activation of preterm and term human labour
would facilitate the development of effective management and inform judgements regarding the necessity for
preterm tocolysis and post-term induction. Prostaglandins act at all stages of human reproduction, and are
potentially activators of labour.
Methods: Expression of 15 genes involved in prostaglandin synthesis, transport and degradation was measured by
qPCR using tissue samples from human placenta, amnion and choriodecidua at preterm and full-term vaginal
and caesarean delivery. Cellular localisation of eight prostaglandin pathway proteins was determined by
immunohistochemistry.
Results: Expression of prostaglandin pathway genes was differentially affected by factors including gestational
age at delivery, and the incidence and duration of labour. Chorioamnionitis/deciduitis was associated with
upregulation of PTGS2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)),
along with the inflammatory genes IL8 (interleukin 8), S100A8 (S100 calcium binding protein A8) and TLR2
(toll-like receptor 2), in amnion and choriodecidua, and with downregulation of CBR1 (carbonyl reductase 1)
and HPGD (hydroxyprostaglandin dehydrogenase 15-(NAD)) in choriodecidua. Protein localisation differed
greatly between the various maternal and fetal cell types.
Conclusions: Preterm and term labour are associated with distinct prostaglandin pathway expression profiles;
inflammation provokes specific changes, unrelated to the presence of labour; spontaneous and induced term
labour are indistinguishable.
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Human labour requires a dramatic transition from a
state of uterine quiescence and immune tolerance of the
fetus—that prevails throughout pregnancy—to a brief
period of intense uterine activation involving connective
tissue remodelling and coordinated smooth muscle ac-
tivity. The signals that initiate this process are not yet* Correspondence: a.lopezbernal@bristol.ac.uk
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unless otherwise stated.known, but among the candidates are the prostaglandins,
which are known regulators of many aspects of reproduct-
ive physiology [1,2]. Evidence suggests that, during uterine
activation there is positive feedback between prostaglan-
dins and inflammatory cytokines that are released by infil-
trating leukocytes [3]. Our early studies demonstrated that
there is a relationship between inflammatory infiltration of
the placenta, fetal membranes and decidua and increased
prostaglandin and leukotriene release [4,5]. Inflammation
has been associated with initiation of term and preterm
labour both in the presence and absence of observable in-
fection [6-12]. It is therefore possible that prostaglandinsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vation. It is important to establish the interactions be-
tween these pathways, both for women at risk of preterm
birth who may be treated with anti-inflammatory drugs
and prostaglandin synthesis inhibitors, and for women
facing post-term induction of labour involving prosta-
glandin treatment.
We previously compared the relative levels of expres-
sion of 15 genes acting in all stages of prostaglandin me-
tabolism (their relationships are illustrated in Figure 1) in
human uterine tissues [13], demonstrating specific capaci-
ties for synthesis and catabolism of PGD2, PGE2, PGF2
and PGI2 in each tissue. We have now made a detailed
examination of these genes in samples of placenta, chorio-
decidua and amnion, demonstrating that factors such as
gestational age and the incidence and duration of labour
are associated with significant changes in expression pat-
terns. We have also characterised the distribution of pros-
taglandin pathway proteins throughout the constituent
cells of the uterus using immunohistochemistry.
We have found distinct uterine prostaglandin gene ex-
pression and immunolocalisation in the presence of inflam-
mation, suggesting uterine activation occurring throughFigure 1 Cellular pathways of prostaglandin (PG) metabolism. A cell is
in precursor prostaglandin synthesis, terminal prostaglandin synthesis, pros
arrows) and products (open circles).increased PTGS2 expression in the fetal membranes and
decreased degradative HPGD in the choriodecidua. Ex-
pression patterns in spontaneous preterm and term labour
without inflammation differed from each other and from
those with inflammatory changes. There were no differ-
ences between spontaneous and induced labour at term.
Methods
Collection of tissue
All women gave written informed consent according
to the requirements of the North Somerset and South
Bristol Research Ethics Committee. Placenta and gesta-
tional membranes were collected immediately post-partum
from the following groups of women: preterm (25–36
weeks gestation) not-in-labour (PNIL), delivery by caesar-
ean section for maternal or fetal complications; spon-
taneous preterm labour (SPL), with vaginal delivery;
term (≥ 37 weeks gestation) not-in-labour (TNIL), de-
livery by elective caesarean section indicated by previous
section and/or breech presentation; spontaneous term
labour (STL), with vaginal delivery; term following induc-
tion of labour (IOL) with intravaginal PGE2 pessary and/
or intravenous oxytocin infusion, with delivery vaginallydepicted, showing enzymatic components (coloured boxes) involved
taglandin transport and prostaglandin inactivation, with reactions (thin
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The women were of mixed parity and all delivered live sin-
gletons. None of the women in preterm labour received
steroid treatment. Tissues were also collected from a group
of women (INF) with evidence of inflammation, as sug-
gested by clinical features of the women (pyrexia or uterine
tenderness) and gross pathology of the delivered placentas,
and confirmed histologically by the presence of leucocyte
infiltration in the fetal membranes (chorioamnionitis), de-
cidua (deciduitis) or placenta (intervillositis), with or with-
out maternal pyrexia or uterine tenderness [4]. Clinical
information for the women providing uterine tissues for
this study is given in Table 1. Tissues from 36 women were
used in this study; tissues from 31 of these women were
previously among those used to study overall levels of
prostaglandin pathway gene expression in placenta and
gestational membranes [13]. Myometrial tissues used in
the previous study were taken from a separate group of
women. Gestational membranes were dissected from be-
tween 1 cm and 4 cm from the placental border. Placental
tissue was dissected from > 5 mm beneath the maternal
surface of the placenta. Tissue samples were dissected im-
mediately after delivery (amnion and choriodecidua were
separated by blunt dissection), washed in sterile phosphate-
buffered saline (PBS), snap-frozen and stored in liquid ni-
trogen. Tissues were also fixed and paraffin-embedded
following standard procedures for immunohistochemistry.
Quantitative real-time PCR (qPCR)
Total RNA was extracted from 100 mg tissue samples by
the guanidine isothiocyanate/phenol method using 1 ml
TRIzol (Invitrogen, Carlsbad, CA, US), giving yields of
10–150 μg. RNA was quantified using a GeneQuant II
spectrophotometer (GE Healthcare, Little Chalfont, UK).
2 μg total RNA was used as a template for cDNA synthe-
sis primed by random primers using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA, US). cDNA was diluted fourfold and 2 μl
used as template for qPCR with the Power SYBR Green













PNIL 8 29 ± 9 33 ± 4 n/a 1.7 ±
SPL 5 27 ± 5 33 ± 1 4 2.0 ±
TNIL 7 31 ± 3 39 ± 2 n/a 4.0 ±
STL 6 31 ± 3 40 ± 1 4 3.6 ±
IOL 5 32 ± 9 40 ± 2 8 3.6 ±
INF 5 36 ± 7 32 ± 6 6 2.0 ±
Values are mean, mean ± standard deviation, or relative numbers in two groups. Ab
induction of labour, PNIL preterm not-in-labour, SPL spontaneous preterm labour, S
term not-in-labour.volume of 20 μl, forward and reverse primer concentra-
tions of 75 nM, and 45 cycles of 95 C for 15 s and 60 C
for 60 s, followed by a dissociation stage, using a 7500
Real-Time PCR System (Applied Biosystems). Two genes
with least Ct variability, POLR2A (polymerase (RNA) II
(DNA directed) polypeptide A, 220 kDa) and ARHGDIA
(Rho GDP dissociation inhibitor (GDI) alpha), were
chosen from five candidates for use as endogenous con-
trols. PCR reaction efficiencies for all primer pairs were
tested by serial template dilution, and were between 90%
and 110%. The ‘sample maximization’ method was used,
with reactions for each gene run on the minimum number
of plates. A standard set of inter-run calibrators was in-
cluded on each plate. Analysis was as previously described
[13]. Sequences for all primers used in this study are given
in Table 2.
Immunohistochemistry
Slide-mounted, paraffin-embedded tissue sections were
dewaxed in Histoclear (National Diagnostics, Atlanta, GA),
hydrated in a graded ethanol series (absolute, 90%, 70%
ethanol) and incubated in 1% (w/w) aqueous hydrogen per-
oxide solution for 15 min to block endogenous peroxidase
activity. Antigen retrieval was achieved by incubation in
citrate buffer (10 mM sodium citrate, pH6.0, 0.05% (v/v)
Tween-20) at 95°C for 20 min. Slides were incubated for
20 min with 2% (v/v) blocking serum, washed with PBS
and incubated overnight with primary antibody at the
following dilutions: PTGS1 (prostaglandin-endoperoxide
synthase 1 (prostaglandin G/H synthase and cyclooxygen-
ase)) 1:60 (sc-1752, Santa Cruz Biotechnology, Santa Cruz,
CA); PTGS2 1:60 (sc-1745); AKR1B1 (aldo-keto reductase
family 1, member B1 (aldose reductase)) 1:200 (in house,
Fortier MA); AKR1C3 (aldo-keto reductase family 1,
member C3) 1:200 (ab27491, Abcam, Cambridge, UK);
CBR1 1:300 (ab4148); PTGES (prostaglandin E synthase)
1:200 (160140, Cayman Europe, Tallinn, Estonia); HPGD
1:300 (in house, Fortier MA); SLCO2A1 (solute carrier or-
ganic anion transporter family, member 2A1) 1:3500 (in






0.7 2:6 n/a 2:6
0.3 0:0 4:1 3:2
0.4 0:7 n/a 4:3
0.4 0:0 5:1 4:2
0.5 1:0 3:2 5:0
1.3 2:0 3:2 4:1
breviations: ARM assisted rupture of the membranes, INF inflammation, IOL
RM spontaneous rupture of the membranes, STL spontaneous term labour, TNIL
Table 2 Primer sequences for quantitative real-time qPCR
Gene Accession Forward primer Reverse primer
PLA2G4A NM_024420 (205) AATGTCATTTATAGATCCTTACC (486) GCATCCATTAACGTAATCTCC
PTGS1 NM_000962 (123) CAGCAGCCGCGCCATGAG (355) ACAGGCCAGGGATGGTGC
PTGS2 NM_000963 (90) CTCAGACAGCAAAGCCTACC (461) ATGTGATCTGGATGTCAACAC
AKR1B1 NM_001628 (71) AGCCATGGCAAGCCGTCTC (317) GCACCACAGCTTGCTGACG
AKR1C3 NM_003739 (53) CAGACAAGTGACAGGGAATGG (448) CCTCACCTGGCTTTAGAGAC
CBR1 NM_001757 (378) CCTGGACGTGCTGGTCAACA (542) ACGTTCACCACTCTCCCTTG
PTGES NM_004878 (50) AGAGATGCCTGCCCACAGC (520) GCTGCTGGTCACAGGTGGC
PTGES2 NM_025072 (1354) ACTCAAGAGCAGGCACCGC (1641) TGCCTTCCCTCTGCTCTGC
PTGES3 NM_006601 (29) GAGAAGTCGACTCCCTAGC (305) TATGCTTGGAATCATTTGGATC
PTGIS NM_000961 (46) AGCCCCGCGATGGCTTGG (439) GAAGAGTCAGTTTCATCCTGG
PTGDS NM_000954 (68) GCAGGAGAATGGCTACTCATC (263) GACAACGCCGCCTTCTTCTC
HPGDS NM_014485 (71) GACATAACACAGAATTGCACC (280) CTGGTGAAGAGTAAGTCCATC
HPGD NM_000860 (3) CTGCACCATGCACGTGAACG (232) AAGTGTCTCTCAGTTGTTGCTG
SLCO2A1 NM_005630 (79) CAGCCATGGGGCTCCTGC (328) GCATTGCTGATCTCATTCAAG
ABCC4 NM_005845 (3472) CAATCATACCTCAGGAACCTG (3758) CTCATCAGTTCTTGGATCCAC
ARHGDIA NM_004309 (358) ACCTGACGGGCGACCTGG (628) GACTTGATGCTGTAGCTGCC
POLR2A NM_000937 (4453) GCACCACGTCCAATGACATTG (4719) GTGCGGCTGCTTCCATAAGC
IL8 NM_000584 (208) CTGTGTGAAGGTGCAGTTTTG (344) GTGTTGGCGCAGTGTGGTC
S100A9 NM_002965 (233) GAGGACCTGGACACAAATGCA (306) CAGGTTAGCCTCGCCATCAG
TLR2 NM_003264 (101) GAGACCTATAGTGACTCCCAG (335) CTGCCCTTGCAGATACCATTG
Sequences written 5’-3’, with corresponding position of 5’-terminal nucleotide in mRNA indicated in parentheses. All sequences are from GenBank at NCBI.
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3% (w/v) BSA. Slides were washed three times in PBS then
incubated for 2 h with biotinylated secondary antibody
(Vectastain ABC signal enhancement kit, Vector Labs,
Burlingame, CA) diluted 1:200 in PBS + 3% (w/v) BSA.
Slides were washed with PBS and incubated for 30 min
with Vectastain ABC streptavidin-HRP (horseradish
peroxidase) conjugate, washed again and incubated with
3,3’-Diaminobenzidine (DAB, Sigma) for antibody-specific
colour development, which was stopped by washing
in PBS, before counterstaining nuclei with Mayer’s
Haemalum, dehydrating in a graded ethanol series followed
by Histoclear and finally coverslip mounting using DPX
mountant.
Data analysis
Associations between levels of gene expression and con-
tinuous clinical variables (maternal and gestational age,
duration of labour) were determined by measuring the
probability of significance associated with the Pearson
correlation coefficient (using the TDIST function in
Excel). Comparisons of expression levels in distinct sub-
groups of subjects were made in Excel with Student’s
t-tests (two-way, not assuming equal variances or equal
sample size).Results
Clinical correlations with PG gene expression
We investigated the possibility of relationships between
clinical features of the subjects and prostaglandin gene
expression levels in uterine tissues.Gestational age
Significant correlation between gestational age at delivery
and prostaglandin gene expression occurred with gene
and tissue specificity, as shown in Figure 2. In women
who were not in labour at delivery, there was a negative
correlation (decreasing gene expression with increasing
gestational age) for PTGES in amnion (p = 0.045), and
positive correlation for HPGDS (hematopoietic prosta-
glandin D synthase) in amnion (p = 0.039), HPGDS,
AKR1C3 and ABCC4 in placenta (p = 0.020, 0.024, 0.046).
In women delivering following spontaneous labour, there
was negative correlation for AKR1B1 and PTGIS (prosta-
glandin I2 (prostacyclin) synthase) in amnion (p = 0.049, <
0.001), and positive correlation for PTGS2 in amnion
(p = 0.007) and AKR1C3 and PTGIS in choriodecidua
(p = 0.026, 0.022). In these women, as expected, gesta-
tional age showed a strong positive correlation with birth
weight (p < 0.001).
Figure 2 Expression of prostaglandin pathway genes in pregnant human uterine tissues. (A) Relative levels of mRNA by ΔΔCt method
following qPCR, log10-transformed, shown as mean ± SD. A, amnion (blue); C, choriodecidua (red); P, placenta (green). PNIL, preterm
not-in-labour; SPL, spontaneous preterm labour; TNIL, term not-in-labour; STL, spontaneous term labour; IOL, induction of labour; INF,
inflammation. Numbers of samples: PNIL = 4; SPL = 4; TNIL = 6; STL = 5; IOL = 5; INF = 4. (B) Statistical comparisons of gene expression.
Relationships with gestational age (g. age) in combined not-in-labour (NIL = PNIL + TNIL) and spontaneous labour (SL = SPL + STL) groups, and with
duration of labour (SPL + STL + IOL) tested by correlation (Pearson’s); level of significance and direction of correlation are indicated. Comparisons
between the presence and absence of labour (preterm and term) and inflammation were tested by Student’s t-tests.
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Gene expression was compared between groups of women
matched for gestational age who delivered with or without
spontaneous labour. With preterm deliveries, expressionwas higher with labour for AKR1B1 in choriodecidua
and PTGIS in placenta (p = 0.032, 0.028). With term de-
liveries, expression was higher with labour for PTGES in
amnion and AKR1C3 in choriodecidua (p = 0.045, 0.033),
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were higher in deliveries without labour (p = 0.043,
0.049, 0.038).
Duration of labour
Duration of labour in spontaneous and induced labour
deliveries ranged from 33 minutes to 17 hours. Pearson
correlation coefficients were calculated to determine the
association between duration of labour and gene expres-
sion. Negative correlation, indicating decreasing expres-
sion with increasing duration, was seen with expression
of CBR1 in amnion (p = 0.006), PTGDS (prostaglandin
D2 synthase 21 kDa (brain)), PTGES3 (prostaglandin E
synthase 3 (cytosolic)), AKR1C3 and CBR1 in choriodeci-
dua (p = 0.049, 0.011, 0.013, <0.001) and AKR1C3 in pla-
centa (p = 0.031). Positive correlation was seen for PTGES2
(prostaglandin E synthase 2) in amnion (p = 0.022) and
SLCO2A1 in choriodecidua (p = 0.010).
Presence of inflammation
Placenta and gestational membranes were collected from
women with uterine inflammation, and PG gene expres-
sion in this group was compared by t-test with expres-
sion in a subgroup of women with no inflammation that
was matched for gestational age and mode of delivery
(Figure 2). Effects of inflammation were limited to up-
regulation of PTGS2 in amnion and choriodecidua (p =
0.022, 0.038), and downregulation of CBR1 and HPGD
in choriodecidua (p = 0.018, 0.011).
Women were assigned to the inflammation group on
the basis of established histological criteria [4], and weFigure 3 Expression of inflammatory genes in pregnant human uterin
qPCR, log10-transformed, shown as mean ± SD. PNIL, preterm not-in-labou
spontaneous term labour; IOL, induction of labour; INF, inflammation. Num
(B) Statistical comparisons of gene expression. No significant relationships
labour groups, between preterm and term not-in-labour or with duration o
expression in the presence and absence of labour at term and of inflamma
of differential comparison are indicated. A, amnion; C, choriodecidua; P, plafurther characterised the inflammatory status of all tissue
samples by measurement of the expression of three genes
known to be involved in inflammatory responses: IL8,
S100A8 and TLR2 (Figure 3). All three genes were signifi-
cantly upregulated in both amnion (p = 0.021, < 0.001,
0.012) and choriodecidua (p = 0.002, <0.001, 0.002) from
women assigned to the inflammation (INF) group. In pla-
centa, the only change was an increase in S100A8 (p =
0.037) with inflammation. Both S100A8 and TLR2 were
expressed at significantly higher levels in choriodecidua
from women in the STL compared to the TNIL group
(p = 0.014, 0.010) confirming a degree of inflammatory
activity in term labour. Levels of both genes also ap-
peared to be higher in SPL rather than PNIL choriodeci-
dua, but these differences were of borderline significance
(p = 0.061, 0.057).
Immunolocalisation of PG pathway proteins in placenta
Low magnification images of H&E-stained placental sec-
tions in Figure 4A show (i) the fetal trophoblastic villi
and intervillous space, which make up the great majority
of the placenta, and (ii) the basal plate, which lies adja-
cent to the uterine wall. Figure 4B-I show placental
immunolocalisation of eight of the PG pathway proteins,
while Figure 4J shows the localisation of vimentin in vil-
lous fibroblasts, vascular cells, macrophages and decid-
ual cells, but not trophoblasts.
In the chorionic plate (the surface of the placenta adja-
cent to the amniotic cavity), the amnion epithelium showed
staining for PTGS2 and PTGES (not shown). Extravillous
cytotrophoblasts, which form an incomplete layer at thee tissues. (A) Relative levels of mRNA by ΔΔCt method following
r; SPL, spontaneous preterm labour; TNIL, term not-in-labour; STL,
bers of samples: PNIL = 4; SPL = 4; TNIL = 6; STL = 5; IOL = 5; INF = 4.
were observed with gestational age in not-in-labour or spontaneous
f labour, so these comparisons are not shown. Comparisons of gene
tion were tested by Student’s t-tests. Level of significance and direction
centa.
Figure 4 Immunohistochemical localisation of PG pathway proteins in the placenta. (A) H&E-stained control indicating structure of (i)
placental villi, interspersed with maternal blood (MB), (ii) basal plate, containing extravillous trophoblasts (EVT) and decidual cells (DC).
(B-K) Higher magnification images of (i) placental villi, indicating syncytiotrophoblasts (ST), vascular cells (VC) and villous macrophages
(VM), (ii) basal plate. (K) Negative control without addition of primary antibody. Scale bar = 50 μm.
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HPGD, PTGES, SLCO2A1, AKR1B1, AKR1C3 and CBR1.
In the placental villi (Figure 4A-K(i)), syncytiotrophoblasts
displayed staining for AKR1B1, HPGD PTGS2, SLCO2A1,
CBR1, AKR1C3, and PTGES. Villous fibroblasts showedPTGS2 and SLCO2A1 staining and heterogeneous AKR1B1
staining. Villous macrophages were positive for PTGS1
and PTGES.
The basal plate of the placenta (Figure 4A-K(ii)) consists of
maternal decidual cells and fetal extravillous cytotrophoblasts,
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partially or thoroughly interspersed. Both decidual cells and
extravillous cytotrophoblasts showed staining for AKR1B1,
PTGS2, HPGD, PTGES, SLCO2A1, AKR1C3, and CBR1.
Staining in the two cell types varied from patient to pa-
tient and even in different regions of the same placental
tissue section, notably with PTGES and HPGD in extravil-
lous cytotrophoblasts. Extravillous cytotrophoblasts clus-
tered in cell islands in the villous placenta had similar
staining patterns (not shown). There was no noticeable
staining for any of these proteins in fibrinoids of the basal
plate (not shown). Protein distribution in the placental cell
populations is summarised in Table 3, along with refer-
ences to previous descriptions of these proteins.
Immunolocalisation of PG pathway proteins in gestational
membranes
Figure 5A-G shows the immunolocalisation of seven of
the PG pathway proteins in amnion and choriodecidua
(PTGS1 is not included as we observed no staining in these
tissues); Figure 5H shows vimentin localisation in decidual
cells, amnion epithelium and fibroblasts of the amnion and
chorion, but not in chorionic trophoblasts. In each panel
a lower magnification image (i) gives a view through a full
section of the membranes, while higher magnification
images show (ii) decidual cells, (iii) chorionic trophoblasts
and chorionic fibroblasts, (iv) amniotic epithelium.
The decidual cells showed staining for AKR1B1, HPGD,
AKR1C3, PTGS2, SLCO2A1 and CBR1. Chorionic tropho-
blasts had staining for HPGD, AKR1B1, CBR1, PTGS2,
PTGES, AKR1C3 and SLCO2A1. AKR1B1, PTGS2, AKR1C3,
HPGD and CBR1 were seen in amniotic and chorionic fi-
broblasts. PTGS2 and PTGES had immunological reac-
tions in amniotic epithelium. This protein distribution is
summarised in Table 3.Table 3 Immunolocalisation of PG pathway proteins in uterin
Protein
PLACENTA
Basal plate Chorionic Villi Chorio
EVT DC ST VF VM VC EVT
PTGS1 [14] [15] +[15] [14]
PTGS2 +[16] + +[14,16] +[15] [15,17] [14]
PTGES +[16] + +[21,22] + [21,22] +
AKR1B1 + + + + +
AKR1C3 + + + +
CBR1 + + + +
SLCO2A1 + + + + +
HPGD +[24] + +[18,24] +
Protein immunolocalisation identified in this study is represented by shaded cells; p
AF amniotic fibroblasts, CF chorionic fibroblasts, CT chorionic trophoblasts, DC decid
syncytiotrophoblasts, VC vascular cells, VF villous fibroblasts, VM villous macrophageInfluence of inflammation in fetal membranes on protein
localisation
Inflammation results in disruption of the fetal membranes,
with highly variable leukocytic infiltration and loss of integ-
rity of the chorionic trophoblast layer. Within a tissue sec-
tion it is common to see regions of massive infiltration with
minimal remaining chorionic trophoblasts, alongside sec-
tions of membrane that appear relatively normal. Figure 6
shows immunolocalisation of prostaglandin proteins in
membranes with a moderate inflammatory reaction, with
considerable leukocytic infiltration but a relatively undimin-
ished chorion. Prostaglandin pathway protein immunolo-
calisation in amniotic epithelium, amniotic and chorionic
fibroblasts, and decidual cells was not noticeably altered
by inflammation. In chorionic trophoblasts, heteroge-
neous expression of PTGS2, PTGES, CBR1 and HPGD
was seen (Figure 6A, B, E & G). In inflammatory leuko-
cytes there was expression of PTGS2, AKR1C3, CBR1 and
PTGES (Table 3 and Figure 6A, B, D & E).
Overlap with previous research
As we have examined multiple members of the prosta-
glandin pathway in three uterine tissues, there is inevitably
a degree of overlap with previous studies of prostaglandin
pathway components. For descriptions of the immunolo-
calisation of prostaglandin pathway proteins, this overlap
has been summarised in Table 3, from which it can be
seen that we are now presenting novel evidence of uterine
immunolocalisation for seven of the eight prostaglandin
pathway proteins studied.
Previous descriptions of prostaglandin pathway gene
expression have focused largely on the cyclooxygenase/
prostaglandin H2 synthase genes PTGS1 and PTGS2
(formerly Cox1 and Cox2). Not all previous observations
can be reconciled with each other.e cell populations
MEMBRANES
nic Plate Choriodecidua Amnion INF
AE DC CT CF AF AE IL
+[18] +[17,19] +[19,20] +[19] +[19] +[17,19,20] +
+ +[21-23] +[21-23] +
+[21] +[19] + +
+[21] +[19] + + +
+ + + + +
+[21] +[19]
+[21] +[18,19,24] + +
revious observations are referenced. Abbreviations: AE amniotic epithelium,
ual cells, EVT extravillous trophoblasts, IL infiltrating leukocytes, ST
s.
Figure 5 Immunohistochemical localisation of PG pathway proteins in the gestational membranes. (A-I(i)) Lower magnification images
show full thickness of membranes, containing amnion epithelium (AE), amnion fibroblasts (AF), chorionic fibroblasts (CF), chorionic trophoblast
(CT) and decidual cells (DC). Higher magnification images show (ii) DC, (iii) CT, CF, (iv) AE. (I) Negative control without addition of primary
antibody. Scale bar = 50 μm.
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Figure 6 Immunohistochemical localisation of PG pathway proteins in gestational membranes with inflammatory infiltration. (A-I) Images
show sections of membranes with chorionic fibroblasts (CF), infiltrating leukocytes (IL), chorionic trophoblast (CT) and decidual cells (DC). (I) Negative
control without addition of primary antibody. Scale bar = 50 μm.
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in PTGS1 expression with gestational age [15], and con-
trasting evidence of decreasing expression with increasing
gestational age at labour [25]. In gestational membranes,
increasing gestational age has been associated with in-
creased [26,27], unchanged [27,28], and decreased [29]
PTGS1 expression. Likewise, the incidence of labour has
been associated with increased [26,27] and unchanged
[30-36] PTGS1 expression.
In the placenta, the existing evidence suggests that
there is no change in expression of PTGS2 with gesta-
tional age or clinical chorioamnionitis [25]. In the gesta-
tional membranes, several studies have shown higher
PTGS2 expression with increasing gestational age [26-29].
There is evidence supporting both increased PTGS2 ex-
pression following labour [26-28,31-35] and no change
with labour [20,36,37].
Information relating to intrauterine expression of other
prostaglandin pathway genes is limited. Our previous
work demonstrated expression of the 15 prostaglandin
pathway genes in placenta, amnion and choriodecidua
[13]. In addition, PLA2G4A (phospholipase A2, group IVA
(cytosolic, calcium-dependent)) expression has been iden-
tified in human placenta and gestational membranes [38],
as has expression of PTGDS and HPGDS [39]. In placenta
and membranes, PTGES expression has shown no change
with labour [21]. Expression of AKR1B1, AKR1C3, HPGD
and SLCO2A1 has been demonstrated in amnion and
choriodecidua [19]. Evidence has been presented in
support of unchanged placental expression of HPGDin response to gestational age, labour and intrauterine
infection [25,40], but also in support of increased expres-
sion with gestational age [41]. In choriodecidua, there is
evidence for lower levels of HPGD mRNA in labour than
not-in-labour [24,37,40,42], with further reductions occur-
ring in the presence of intrauterine infection [40].
Discussion
The human placenta, fetal membranes and decidua pro-
duce prostaglandins throughout pregnancy with a large
increase at parturition, but the precise roles of these pleio-
tropic mediators are yet to be determined. The prostaglan-
din metabolic pathway consists of anabolic and catabolic
components, as well as trans-membrane transporters
(Figure 1). We have characterised prostaglandin pathway
gene expression and protein localisation in placenta, am-
nion and choriodecidua from women delivered at different
gestational ages with or without labour, induction and
intrauterine inflammation. We have described novel pro-
tein localisation and gene expression patterns that increase
our understanding of the roles of prostaglandins in human
pregnancy and labour.
The placenta is the interface between the maternal
and fetal blood supplies, allowing nutrient and waste ex-
change across the thin syncytiotrophoblast layers of nu-
merous highly vascularised fetal villi projecting directly
into the placental pool of maternal blood. As the fetal tis-
sues are allogeneic to the maternal tissues, there must be
mechanisms at this interface to prevent a maternal im-
mune response to the fetus. We have identified similar
Phillips et al. BMC Pregnancy and Childbirth 2014, 14:241 Page 11 of 14
http://www.biomedcentral.com/1471-2393/14/241patterns of protein localisation in decidual cells and extra-
villous trophoblasts of the placental bed and syncytio-
trophoblasts of placental villi. These cells all express
AKR1B1, PTGS2, HPGD, PTGES, SLCO2A1, AKR1C3
and CBR1, thus having the capacity for PGF2 and PGE2
synthesis and PG uptake and degradation. Gene expres-
sion patterns described here and in our previous work
[13] support these observations and we now describe the
presence of PGD2, PGE2 and PGI2 synthases in the pla-
centa. Comparisons of placental gene expression in differ-
ent groups of women identified increasing HPGDS,
AKR1C3 and ABCC4 with gestational age in the absence
of labour, and higher PTGIS in labour than not-in-labour
preterm.
The fetal membranes consist of the fetal amnion and
chorion and the attached maternal decidua, which to-
gether comprise a major structural element of the uter-
ine tissues and have endocrine functions in pregnancy
and parturition not yet fully elucidated [43]. As in the
placenta, the trophoblast and decidua are the interface
between maternal and fetal tissues. Immunolocalisation
of prostaglandin pathway proteins in chorionic tropho-
blast cells and adjacent decidua are similar to each other,
and to some extent resemble placental patterns, with
HPGD, AKR1B1, AKR1C3, CBR1, PTGS2 and SLCO2A1
expressed in choriodecidua. Unlike in placental cells,
variable protein expression is evident in choriodecidua,
with the immunolocalisation of PTGES in chorionic
trophoblast but not decidua, and higher chorionic levels
of CBR1, and decidual levels of AKR1C3. Prostaglandin
gene expression changes in choriodecidua include increased
AKR1C3 and PTGIS with gestational age and labour, with
higher AKR1B1 in labour preterm, and higher AKR1C3 in
labour at term compared with not-in-labour.
In the region between the chorionic trophoblast and
amniotic epithelium, fibroblasts express PTGS2, PGF2
synthases and HPGD, while the amniotic epithelium it-
self, which is known to be a source of PGE2 synthesis
[43,44], expresses PTGS2 and PTGES proteins, and also
high levels of PTGS2, PTGES and PTGES3 mRNA. Both
PTGS2 and PTGES are differentially expressed in am-
nion, with PTGS2 increasing with gestational age in the
presence of labour, and PTGES decreasing as gestational
age rises in the absence of labour, and displaying higher
expression in labour than not-in-labour at term. Despite
previous observations of increased levels of prostaglan-
dins and their metabolites in amniotic fluid with labour
[39,45,46], we did not observe a significant alteration in
PTGS2 in amnion and choriodecidua with either pre-
term or term labour.
Taken together, these expression patterns suggest dis-
tinct roles for prostaglandin metabolism in tissues at the
maternal:fetal interface and in tissues within the fetal com-
partment. At the interface there is the ability to synthesisePGD2, PGE2, and PGF2, but these prostaglandins might be
limited to autocrine or paracrine function by the co-
expressed degradative complex of SLCO2A1 and HPGD,
which is considered to be a barrier between the maternal
and fetal prostaglandin systems [24,47,48]. These prosta-
glandins could participate in the immunomodulation of
maternal leukocytes present in decidua, placental bed and
maternal blood, to prevent rejection of the fetal tissues.
PGE2 synthesised in the amnion and released into the
amniotic fluid could influence fetal physiology, for ex-
ample by inhibiting fetal breathing [49]. The reduction
in amniotic PTGES expression and amniotic fluid PGE2
[8] with increasing gestational age might then allow lung
movements to develop in sync with fetal maturation. It
should, of course, be noted that PTGES is the only one of
the three PGE2 synthases that displays this dependence on
gestational age for amniotic expression. PTGES is also the
only PGE2 synthase that shows higher expression in the
amnion than in the other tissues. Furthermore, as amniotic
expression of both SLCO2A1 and HPGD are some orders
of magnitude lower than in placenta and choriodecidua, it
suggests that there is sufficient degradation of the PGE2
that is released into the amniotic cavity in fetal tissues,
such as the lung, to prevent accumulation in the amniotic
fluid.
In addition to gestational age and the incidence of labour,
we investigated the correlation of prostaglandin gene ex-
pression with other characteristics. Duration of labour was
associated with different expression changes in each of the
tissues, with both upregulation and downregulation of
prostaglandin genes. The only gene to be affected by both
duration of labour and the presence or absence of labour
was AKR1C3 in the choriodecidua. This suggests that
regulation of some genes is associated with the process of
labour, regardless of its duration, whereas others are af-
fected by exposure to the prolonged stressful effects of
labour. As we could not follow gene expression through-
out labour, we cannot rule out that the differential regula-
tion of these genes is a cause rather than an effect of the
duration of labour. In a rarely quoted study involving >200
deliveries, Keski-Nisula et al. demonstrated that decidual
inflammation is significantly more common in women in
advanced labour compared to early labour, and concluded
that the inflammatory changes are more likely to be a con-
sequence of labour rather than its cause [50]. Given the
traumatic effects of labour on both mother and child, elu-
cidating the true nature of this relationship could provide
valuable information.
We were very interested in evaluating the presence or
absence of intrauterine inflammation. There has been a
great deal of effort expended on establishing the causative
relationship between intrauterine infection, inflammation
and labour, particularly preterm labour. The premature ac-
tivation of inflammatory pathways by intrauterine infection
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labour [51,52]. Amniotic fluid metabolomic profiles differ
in women delivering preterm in the presence and absence
of intra-amniotic infection and inflammation [53].
We compared gene expression in a group of women with
histological signs of inflammation with expression in a
group of women matched for gestational age at delivery,
and without substantial differences in other recorded vari-
ables, but with no signs of inflammation. To confirm the
histological observations of inflammation, we measured the
expression of three known inflammatory genes, finding sig-
nificant upregulation of all three in amnion and choriodeci-
dua samples from the INF group. Among the prostaglandin
pathway genes, PTGS2 was upregulated with inflammation
in both amnion and choriodecidua, whereas CBR1 and
HPGD were downregulated in choriodecidua. In the pla-
centa only one of the inflammatory control genes was
upregulated, and none of the prostaglandin genes was af-
fected by inflammation, but as the intrauterine inflamma-
tion was largely limited to chorioamnionitis/deciduitis, we
cannot rule out that placentas affected by villitis, which
show altered leukotriene synthesis [5], would also show
prostaglandin pathway expression changes. The unique
expression patterns of prostaglandin pathway and inflam-
matory control genes that we have observed suggest
that in cases of uncomplicated spontaneous preterm labour,
there is no underlying inflammatory expression profile.
There must be an alternative mechanism for uterine ac-
tivation in SPL in the absence of inflammation. In this
regard it is worth mentioning that oxytocin, a strong utero-
tonic agent, stimulates PTGS2 expression in human myo-
metrial cells through previously undescribed pathways such
as NFAT (nuclear factor of activated T cells) [54].
Although these results support the idea that labour
usually occurs in the absence of inflammation, there is
evidence that the presence of inflammation can be a
trigger for labour, with [8,12] or without [10,12] signs of
infection. This delivery mechanism can provide a re-
sponse to intrauterine infections that can threaten the
lives of mother and fetus. Tocolysis is not always an ap-
propriate treatment, even for very early preterm labour,
as the uterus can become a hostile environment. How-
ever, when infections can be overcome, and in instances
of premature labour without infection and/or inflamma-
tion, there are great potential benefits to effective tocoly-
sis. Our observation of different prostaglandin pathway
expression profiles in preterm labour and inflammation
could have implications for the choice of tocolytics used
in different situations. Although elevation of PTGS2 in
placenta and membranes affected by inflammation could
be countered by selective PTGS2 inhibitors, PTGS2 is
not upregulated with preterm labour in these tissues, al-
though it is in myometrium [13]. Better understanding
of the roles of PTGS2 in the different uterine tissues inpreterm and term labour with and without inflammation
could clarify when PTGS2 inhibitors are most likely to
be effective.
We observed an increase in PTGS2 expression in the
amnion with term versus preterm labour that has also
been seen previously [31,32,55]. An increase in amniotic
fluid IL1 (interleukin 1) with labour at term has been de-
scribed [56], and could be responsible for the PTGS2 up-
regulation, although as with other observations in this
field, there is contradictory evidence suggesting lower
IL1 at term [8]. Increased PTGS2 expression induced by
cytokines, would explain the upregulation of PTGS2 in
the inflamed membranes of chorioamnionitis.
Limitations of this study include the numbers of sam-
ples in each of the groups; there is no enough data to
correlate with previous preterm deliveries, hypertension,
BMI, asthma, smoking and socioeconomic status of the
women. Immunohistochemistry was used as a qualitative
assay for only a subset of the prostaglandin pathway pro-
teins, so that no quantitative data on protein levels were
obtained. Another potential limitation is the lack of stat-
istical correction for multiple comparisons, which could
lead to type I errors of false positive identification of
statistical significance. However, in order to avoid type II
errors of rejection of true significance, we have pre-
sented the results of our statistical tests uncorrected,
with the caveat that further studies are required before
the changes that we have identified can be unequivocally
confirmed.
Conclusions
The principal aim of our research is to identify the causes
of preterm labour, to enable reliable prediction of its oc-
currence and to facilitate its prevention by identifying bio-
chemical pathways suitable for intervention. In light of
considerable evidence linking prostaglandin function with
uterine activation, we have undertaken a detailed analysis
of prostaglandin pathway gene expression in human pla-
centa, amnion and choriodecidua, identifying changes in
association with gestational age, labour, inflammation and
duration of labour, although there were no significant dif-
ferences between spontaneous and induced labour at term.
Inflammation provokes specific changes, unrelated to the
presence of labour. The use of tocolytics should take into
account these differences, in particular between uncom-
plicated spontaneous preterm labour and chorioam-
nionitis. Greater understanding of the different PG pathway
changes in idiopathic and inflammation-associated pre-
term labour should facilitate the targeting of appropriate
pharmacological intervention to these very different
groups of women.
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